
Sign up to save your podcasts
Or


Subscriber-only episode
Resources for the Community:
___________________________________________________________________
https://linktr.ee/theplussidezpodcastÂ
Ro - Telehealth for GLP1 weight managementÂ
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
Health Education Labor & Pensions Committee WebsiteÂ
https://www.help.senate.gov/
Direct Link to Senate Hearing
https://www.help.senate.gov/hearings/why-is-novo-nordisk-charging-americans-with-diabetes-and-obesity-outrageously-high-prices-for-ozempic-and-wegovy
___________________________________________________________________
On September 24, 2024, the U.S. Senate's Health, Education, Labor & Pensions Committee held a crucial hearing titled "Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?" This hearing gained even greater significance with the recent news of the Tirzepatide injection being removed from the FDA's shortage list, emphasizing the ongoing challenges in medication accessibility.
In a tense atmosphere, Novo Nordisk CEO Lars Jorgensen faced rigorous questioning about the soaring prices of these essential diabetes and obesity medications. Lawmakers and healthcare advocates pressed for transparency, shedding light on broader issues of healthcare affordability that affect millions of Americans.
With the stakes exceptionally high, the revelations from this hearing are poised to ignite further discussions in the ongoing battle for equitable healthcare access nationwide. The event not only highlighted the urgent need for reform but also called into question the ethics of pharmaceutical pricing in the United States, underlining the critical importance of making life-saving medications affordable for all.
This is the Highlight reel from the 2 hour hearing showing what The PlusSidez believes to be crucial take away,
______________________________________________________________________
âď¸Mounjaro Stanleyâď¸
griffintumblerco.Etsy.com
Use code PODCAST10 for $ OFF
______________________________________________________________________
Join this channel to get access to perks:
  / @theplussidez
_____________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovyÂ
Send us Fan Mail!
Kim Carlos, Executive Producer
TikTok
https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc
https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr
Kat Carter, Associate Producer
TikTok
https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc
https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
By Kim Carlos4.5
205205 ratings
Subscriber-only episode
Resources for the Community:
___________________________________________________________________
https://linktr.ee/theplussidezpodcastÂ
Ro - Telehealth for GLP1 weight managementÂ
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
Health Education Labor & Pensions Committee WebsiteÂ
https://www.help.senate.gov/
Direct Link to Senate Hearing
https://www.help.senate.gov/hearings/why-is-novo-nordisk-charging-americans-with-diabetes-and-obesity-outrageously-high-prices-for-ozempic-and-wegovy
___________________________________________________________________
On September 24, 2024, the U.S. Senate's Health, Education, Labor & Pensions Committee held a crucial hearing titled "Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?" This hearing gained even greater significance with the recent news of the Tirzepatide injection being removed from the FDA's shortage list, emphasizing the ongoing challenges in medication accessibility.
In a tense atmosphere, Novo Nordisk CEO Lars Jorgensen faced rigorous questioning about the soaring prices of these essential diabetes and obesity medications. Lawmakers and healthcare advocates pressed for transparency, shedding light on broader issues of healthcare affordability that affect millions of Americans.
With the stakes exceptionally high, the revelations from this hearing are poised to ignite further discussions in the ongoing battle for equitable healthcare access nationwide. The event not only highlighted the urgent need for reform but also called into question the ethics of pharmaceutical pricing in the United States, underlining the critical importance of making life-saving medications affordable for all.
This is the Highlight reel from the 2 hour hearing showing what The PlusSidez believes to be crucial take away,
______________________________________________________________________
âď¸Mounjaro Stanleyâď¸
griffintumblerco.Etsy.com
Use code PODCAST10 for $ OFF
______________________________________________________________________
Join this channel to get access to perks:
  / @theplussidez
_____________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovyÂ
Send us Fan Mail!
Kim Carlos, Executive Producer
TikTok
https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc
https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr
Kat Carter, Associate Producer
TikTok
https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc
https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

2,201 Listeners

333 Listeners

141 Listeners

611 Listeners

48 Listeners

1,639 Listeners

388 Listeners

244 Listeners

364 Listeners

36 Listeners

85 Listeners

168 Listeners

413 Listeners

14 Listeners

44 Listeners